Clinical decline in Alzheimer’s requires plaque and proteins
Tuesday, April 24th, 2012The neuron-killing pathology of Alzheimer’s disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of an altered protein called p-tau.
See original here:
Clinical decline in Alzheimer’s requires plaque ... continue reading